News About: Pharm. Industry
Drug seminar focuses on economies of biosimilars
The economics of biologics will grow more challenging, especially as demand increases as the financial model of the industry has been built on aggressive pricing of drugs intended for use in a limited number of patien...
Sales of domestic pharmaceutical firms up 20% in October
The combined sales of the nine major domestic pharmaceutical manufacturing firms in October marked a growth rat of more than 20 percent from the same month of last year, according to market analysts.
Boosted by rob...
Direct dealing is hot potato to multinationals
The issue of direct transaction with local wholesalers is likely to become a hot potato between multinational companies and domestic wholesales.
“We hope foreign drug makers will promote a win-win spirit with us fo...
Allegan Korea to release anti-wrinkle agents
Allergan Korea plans to launch two types of hyaluronic acid fillers - Juvederm Ultra and Ultra Plus injectable gels from next month.
Juvederm injectable gel is a colorless hyaluronic acid gel that is injected into ...
Government OKs sales of locally-produced flu vaccine for infant
Korea's health authorities gave the green light to a local pharmaceutical company on November 16 to sell the nation's first vaccine for type-A (H1N1) influenza for infants aged from six months and less than 3 years.
...
Handok embarks on direct transaction with Dongwon
Handok Pharm signed an agreement with Seokwon Pharm and Dongbo Pharm, affiliated companies of Dongwon Group Pharma, to initiate a direct dealing with them, it was learned on November 16.
Officials at Seokwon Pharm ...
Concerns growing over low-priced drug incentive system
There are mounting concerns in the local pharmaceutical industry over the spreading rumor that the government is said to push up with a plan to offer an incentive to a medical institution which purchases a drug at a c...
Pharmaceutical firms urged to go global
Local pharmaceutical companies will need to expand their businesses abroad to enlarge and diversify their customer base while creating opportunities to develop their own biosimilars, industry sources said.
"Local c...
Huh, Green Cross Chairman, passed away
Huh Young-sup, chairman of Green Cross, died of a long-term illness on November 15, it was learned on November 16. He was 69.
Huh was a pioneer of home-grown biomedicine in the development of many "first vaccines"...
Competition seen intensified for proton pump inhibitors market
As Ilyang Pharm is poised to join the PPI market by launching newly developed antiulcerant agent Noltec (ilaprazole) within this year, marketers may need to come up with more distinguished strategies, said an industry...
